Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.
A team of international researchers has found a promising new drug candidate for the treatment of Alzheimer’sdisease. The scientists say they have developed a peptide inhibitor called RI-AG03 ...